Solution
Industries
Resources
About
Beacon Search

Cancer Profiling and Pathways: Technologies and Global Markets

Report Code: BIO073A

Publish Date: Sep 2010

Publisher: BCC Publishing

Category: Cell Biology

Customize This Report

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

  • BCC estimates the global market for Cancer Profiling Technologies at about $15 billion in 2009.  BCC expects the market to reach $17.7 billion in 2010 and $47 billion by 2015, at a compound annual growth rate (CAGR) of 21.6% over the next 5 years.
  • Proteomics were worth $7.9 billion in 2009. This segment is expected to increase to $9.4 billion in 2010 and reach $19.5 billion by 2015, at a compound annual growth rate (CAGR) of 15.6%. 
  • Genomics were the second-largest application segment, with nearly $6 billion in 2009.  While remaining the second-largest market segment, its share of the global market is expected to increase to a $10.5 billion by 2015.
  • Epigenetics/methylation and microRNA are the other two products where former being the third largest with expected percentage of $17 billion by 2015 and latter being the last with $98.1 million by 2015.

INTRODUCTION

STUDY GOALS AND OBJECTIVES
 
This BCC Research report, BIO073A Cancer Profiling and Pathways: Technologies and Global Markets, provides a detailed overview and thorough analysis and insight of the present and future cancer profiling and pathways. This report analyzes in detail the cancer profiling and tools markets. This report includes products in this market, and detailed analyses of markets and competitive environments, cancer markets in newly emerging tools, diagnostics and therapeutics, and their impacts on the market. The report includes information about significant products, key players, issues and trends, current market status of cancer profiling methods, strengths, weaknesses, opportunities and challenges, major issues involved in the research and development (R&D) of more effective cancer profiling techniques, and new cancer therapeutics in development and in clinical trials.
 
REASONS FOR DOING THE STUDY
 
Gene expression profiling methods enable the detection and measurement of multiple expressed gene transcripts in a single RNA sample. Continually evolving methods, such as microarray analysis, multiplex PCR, and quantitative real-time PCR, are integral to deciphering the molecular mechanisms involved in gene function, biological development, and disease progression, and are important tools in the discovery and development of new drug targets and diagnostic biomarkers. Life Technologies, Applied Biosystems division, and Affymetrix, respectively, are maintaining their leads in the quantitative real-time PCR and microarray market segments. Understanding the multivariate nature of cancer and drug response also depends on molecular profiling at epigenetic, genetic, and protein levels. A major challenge is to develop an understanding of this multivariate dysregulation, with respect both to how it arises from diverse genetic mutations and to how it may be ameliorated by prospective treatments. High-throughput experimental platform technologies ranging from genomic sequencing to transcriptomic, proteomic, and metabolomic profiling are now commonly used for molecular-level characterization of tumor cells and surrounding tissues. The global cancer profiling market is projected to be valued at $40.3 billion by 2015, growing at a compound annual growth rate (CAGR) of 20.8% from 2009 to 2015, driven by the high demand for novel and specific biomarkers in the field of drug discovery. The increasing use of biomarkers in clinical services is boosting the overall biomarker service market. The high growth of the biomarker market is boosted by the demand from the baby boomer generation in the U.S., and from Asia’s emerging IT industry.
 
SCOPE OF REPORT
 
Cancer biomarkers have gained significant importance in the drug-development process, and the market is an emerging segment. To gain an understanding of the market dynamics, market size, and competitive landscape needs a detailed analysis of cancer biomarker market and cancer profiling technologies and new developments. This report’s exhaustive market segmentation captures relevant data regarding biomarker tools, services, and application markets, and thereby provides a complete picture of the cancer-profiling market. The proposed report will give an update on Cancer Profiling and Pathways: Technologies and Global Markets. It will review global markets for cancer profiling and biomarker studies and will forecast trends for use of technologies through 2015. Important cancer profiling techniques, market share by type of products on the market and market share by company, information for types of cancers and biomarkers will be provided. The report also includes current issues and trends affecting the industry, costs, and factors influencing demand.. The report covers epigenetic, methylation and miRNA products in development, products in clinical trials, currently marketed and clinical-stage development products. The report categorizes the biomarkers and profiling market and provides market data, market drivers, trends and opportunities, top-selling products, key players, and competitive outlook. This report will also provide market tables and also provides company profiles.
 
The following technologies and segments are excluded from this report: detailed instruments, pharmacogenomics, combinatorial chemistry, biochip, bioinformatics, and high-throughput screening (HTS). Uses of emerging technologies in drug discovery such as lab-on-a-chip (LOAC), nanotechnology, and RNA interference (RNAi) also are not discussed here.
 
INTENDED AUDIENCE
 
This report is an exhaustive study on the cancer profiling and pathways, giving crucial statistics and analysis on the market structure, market size, key technologies and segments, important trends in technology development, next-generation technologies, major opportunities, and market shares of key players and innovative drugs. This report may prove crucial for the firms or investors seeking investments in the concerned sector. As market needs change with progress, the value of the information provided from microarrays, sequencing, and qRT-PCR has become more interesting for markets outside of basic life-science research. In oncology-expression pattern profiling, comparing expression in normal and cancer tissues shows an unexpected greater reliability in classifying cancer types than the signatures of protein-coding genes. Researchers have also successfully classified poorly differentiated tumors using expression profiles. Along with their diagnostic potential, cancer-profiling techniques have also reportedly proven to be of prognostic value to predict survival among cancer patients and poor responsiveness to adjuvant chemotherapy and other drugs.
 
METHODOLOGY
 
Both primary and secondary research methodologies were used in preparing this report. Secondary sources include books, newspapers, trade journals, white papers, industry portals, government agencies, trade associations, monitoring industry news and developments, and through access to paid databases. The base year of the report is 2009, with forecast data provided through 2015. Historical, base year, and forecast data are provided for each market segment of this report. Growth rates are determined through a compilation of data, including past trends, future trends, products in R&D, and current product growth, etc.
 
ANALYST CREDENTIALS
 
Usha Nagavarapu is an experienced pharmaceutical professional with business development experience. She has more than 10 years of preclinical, alliance management, discovery, and technology development marketing experience. Her strong focus areas include oncology and cardiovascular diseases, with expertise in molecular and cell biology and complex cell-based biological assays, ranging from drug discovery, in vitro and in vivo screening, in vivo model development, and pharmacokinetics. She has experience working with early start-ups.
 
BCC ONLINE SERVICES
 
BCC Research offers an online information retrieval service. BCC’s home page, located at www.bccresearch.com, enables readers to:
 
BCC ONLINE SERVICES
 
BCC offers an online information retrieval service. BCC’s home page, located at www.bccresearch.com, enables readers to:
  • Examine BCC’s complete catalog of Market Research Reports and place direct orders
  • Subscribe to any of BCC’s many industry newsletters
  • Read announcements of recently published reports and newly launched newsletters
  • Register for BCC’s well-known conferences
  • Request additional information on any BCC product
  • Take advantage of special offers 
DISCLAIMER
 
The information developed in this report is intended to be as reliable as possible at the time of publication and of a professional nature. This information does not constitute managerial, legal, or accounting advice; nor should it serve as a corporate policy guide, laboratory manual, or an endorsement of any product, as much of the information is speculative in nature. The author assumes no responsibility for any loss or damage that might result from reliance on the reported information or its use. 
Need pricing for multiple titles, a complete report bundle, or something specially curated to fit your budget? EXPLORE OFFERS
Let us assist you! Our analysts are ready to tailor this report to your specific need. Talk to Our Analyst

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
[+] Show Chapter Details
Title/Chapter NamePagesMember Price
Full Report: Cancer Profiling and Pathways: Technologies and Global Markets343Free
Chapter- 1: INTRODUCTION4Free
Chapter- 2: SUMMARY3Free
Chapter- 3: OVERVIEW13Free
Chapter- 4: CURRENT PROFILING TECHNIQUES233Free
Chapter- 5: BIOINFORMATICS, DATABASES, AND PATHWAY ANALYSIS3Free
Chapter- 6: CANCER PROFILING AND CASE STUDIES24Free
Chapter- 7: MARKET49Free
Chapter- 8: SELECTED LICENSING, COLLABORATIONS AND MERGERS4Free
Chapter- 9: C. CRAMER & CO. GMBH7Free

Related Reports

Track the Latest Global Tariff Developments

In today's fast-paced global economy, tariffs are no longer static—they are dynamic levers shaped by geopolitical realignments, supply chain vulnerabilities, inflationary pressures, and sustainability-driven trade reforms. As governments worldwide recalibrate their trade strategies, businesses are left to navigate a maze of shifting rules, rising costs, and regulatory uncertainty.

Our analysis empowers you with real-time updates and in-depth expert analysis on all facets of global tariff activity. From new trade agreements and sanctions to abrupt tariff hikes and retaliatory duties, we monitor developments across borders, sectors, and industries—so you don't have to.

Whether it's the ongoing U.S.–China trade dynamics, the evolving EU Carbon Border Adjustment Mechanism (CBAM), or the emerging policies in India, ASEAN, and Latin America, we provide full-spectrum coverage. We also track multilateral trade negotiations, World Trade Organization (WTO) rulings, and sector-specific duty structures—ensuring you are always ahead of global trade shifts.

With our analysis, you can stay informed, identify risks, and confidently respond to tariff changes—no matter where you operate.

Ready to see what tariff means for your business?

Consult with our experts or request your custom Tariff Impact Brife today

Stay Informed, Stay Competitive

In today's interconnected and unpredictable global economy, staying ahead of tariff shifts is not just important—it's essential. BCC Research provides decision-makers with trusted, research-driven insights that turn uncertainty into opportunity.

Our in-depth market analysis and trade intelligence help you decode how tariff changes impact your specific sector—manufacturing, healthcare, technology, agriculture, or energy. We break down complex data into actionable knowledge through comprehensive reports, expert commentaries, and sector-focused forecasts.

Our analysis includes:

  • Thorough breakdowns of current and proposed tariff policies and how they affect regional and global trade flows.
  • Sector-specific implications, helping you understand the strategic impact on sourcing, pricing, and competitiveness.
  • Forward-looking insights to support risk management, planning, and response strategies for evolving trade conditions.

With BCC Research, you gain more than just information—you gain clarity and confidence to make well-informed decisions in a volatile trade environment.

Don't let tariffs catch you off guard—let our insights guide your strategy.

This is an Excel-only version of the report.

Report Includes

    Total Number of Tables in this Report: 77

  • Summary Table: MARKET FOR CANCER PROFILING TECHNOLOGIES, THROUGH 2015
  • Table 1: DIFFERENT TOOLS FOR MOLECULAR PROFILING OF CANCER
  • Table 2: LIST OF TECHNIQUES/TOOLS FOR GENOMIC PROFILING
  • Table 3: GENOMIC REVENUE AND FORECAST, THROUGH 2015
  • Table 4: COMMONLY USED DNA MICROARRAYS
  • Table 5: SELECTED COMPANIES WITH MICROARRAY TECHNOLOGIES
  • Table 6: COMPANIES WITH SEQUENCING TECHNOLOGIES
  • Table 7: SEQUENCING PATENTS AWARDED
  • Table 8: MUTATIONS IDENTIFIED IN CANCER
  • Table 9: TRANSCRIPTOMIC TECHNIQUES
  • Table 10: miRNA AND SIRNA-A COMPARISON
Sample Report

Recent Reports

Global DNA Read, Write, and Edit Market

Published - Mar 2026 | Publisher - BCC Publishing | Code - BIO193B

The global market for DNA read, write, and edit was valued at $25.9 billion in 2025 and is estimated to reach $67.7 billion by 2030, at a compound annual growth rate (CAGR) of 21.2% from 2025 through 2030.

Validation, Calibration, and Standardization in the Life Sciences Market

Published - Mar 2026 | Publisher - BCC Publishing | Code - BIO179B

The global market for validation, calibration, and standardization in life sciences was valued at $2.8 billion in 2025 and is estimated to reach $3.9 billion by 2030, at a compound annual growth rate (CAGR) of 6.7% from 2025 through 2030.

Cloud Computing in Cell Biology, Genomics and Drug Development: Global Markets

Published - Feb 2026 | Publisher - BCC Publishing | Code - BIO200B

The global market for cloud computing in cell biology, genomics and drug development is estimated to grow from $7.2 billion in 2025 to $15.6 billion by the end of 2030, at a compound annual growth rate (CAGR) of 16.7% from 2025 through 2030.

Decentralized Clinical Trials: Global Markets

Published - Feb 2026 | Publisher - BCC Publishing | Code - BIO275A

The report provides an overview of the global decentralized clinical trials (DCT) market and analyzes market trends. It includes global revenue ($ Million) for the base year data of 2024 and for the forecast period 2025 through 2030.

Central Nervous System (CNS) Biomarkers: Technologies and Global Markets

Published - Feb 2026 | Publisher - BCC Publishing | Code - BIO074E

The global market for central nervous system (CNS) biomarkers is estimated to grow from $7.6 billion in 2025 to reach $13.8 billion by the end of 2030, at a compound annual growth rate (CAGR) of 12.6% from 2025 through 2030.

Top Trending Reports

Stem Cell and Regenerative Therapy: Global Markets

Published - Feb 2026 | Publisher - BCC Publishing | Code - BIO191B

The global market for stem cell and regenerative therapy is projected to grow from an estimated $16.7 billion in 2025 to $43.8 billion by 2030, at a compound annual growth rate (CAGR) of 21.3% from 2025 to 2030.

Infusion Pumps and Devices: Technologies and Global Markets

Published - Mar 2026 | Publisher - BCC Publishing | Code - HLC071F

The global market for infusion pumps and devices is expected to grow from $9.7 billion in 2025 and is projected to reach $14.2 billion by the end of 2030, at a compound annual growth rate (CAGR) of 7.9% during the forecast period of 2025 to 2030.

Validation, Calibration, and Standardization in the Life Sciences Market

Published - Mar 2026 | Publisher - BCC Publishing | Code - BIO179B

The global market for validation, calibration, and standardization in life sciences was valued at $2.8 billion in 2025 and is estimated to reach $3.9 billion by 2030, at a compound annual growth rate (CAGR) of 6.7% from 2025 through 2030.

Noninvasive Cancer Diagnostics: Technologies and Global Markets

Published - Mar 2026 | Publisher - BCC Publishing | Code - HLC197B

The global market for noninvasive cancer diagnostic technologies is expected to grow from $119.9 billion in 2025 and is projected to reach $165.2 billion by the end of 2030, at a compound annual growth rate (CAGR) of 6.6% during the forecast period of 2025 to 2030.

Neuroprotective Agents: Therapeutic Applications and Global Markets

Published - Feb 2026 | Publisher - BCC Publishing | Code - PHM188B

The global market for neuroprotective agents is expected to grow from $43.9 billion in 2025 and is projected to reach $60.9 billion by the end of 2030, at a compound annual growth rate (CAGR) of 6.7% during the forecast period of 2025 to 2030.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Cancer Profiling and Pathways: Technologies and Global Markets
Customize This Report
Customize Report
Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.
Contact
© 2025 BCC Research
Privacy Policy |Site Map|Terms & Conditions
AI Sentiment